Efficacy and safety of immunoglobulin apheresis

ASAIO Journal

Volumn 43, Issue 1, 1997, Pages 53-59

  Richter, W O ^a   Donner, M G ^a   Selmaier, A ^a   Hiller, E ^a   Schwandt, P ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BLOOD; CELLS; DISEASES; LIVING SYSTEMS STUDIES;

AUTOIMMUNE DISEASES; IMMUNOGLOBULIN APHERESIS;

IMMUNOLOGY;

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANAPHYLAXIS; APHERESIS; ARTICLE; AUTOIMMUNITY; CASE REPORT; FEMALE; HUMAN; HYPOCALCEMIA; HYPOTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PLASMAPHERESIS; SAFETY; TECHNIQUE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0342378136     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199743010-00010     Document Type: Article

References (35)

1. Drachman DB, De Silva S, Ramsay D, Pestronk A: Humoral pathogenesis of myasthenia gravis. Ann N Y Acad Sci 505: 90-105, 1987.
2. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL: Serum antibodies to GM1, CDIb, peripheral nerve myelin, and campylobacter jejuni in patients with Guillain-Barre syndrome and controls: Correlation and prognosis. Ann Neurol 34: 130-135, 1993.
3. McMillan R: Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304: 1135-1147, 1981.
4. Smith BR, Hall R: Thyroid-stimulating activity in immunoglobulins in Graves' disease. Lancet ii: 427-430, 1974.
5. Bygren P, Rasmussen N, Isaksson B, Wieslander B: Anti-neutrophil cytoplasm antibodies, anti-GBM antibodies and anti-dsDNA antibodies in glomerulonephritis. Eur J Clin Invest 22: 783-792, 1992.
6. Weber MF: Antineutrophil-cytoplasmatic antibodies and antiglomerular basement membrane antibodies in Goodpasture syndrome and Wegener's granulomatosis. J Am Soc Nephrol 2: 1227-1234, 1992.
7. Siegel SC: Corticosteroid agents: Overview of corticosteroid therapy. J Allergy Clin Immunol 76: 312-320, 1985.
8. Council for scientific affairs: Current status of therapeutic plasmapheresis and related techniques: Report of the AMA panel on therapeutic plasmapheresis. JAMA 253: 819-825, 1985.
9. Reimann PM, Mason PD: Plasmapheresis: Technique and complications. Intensive Care Med 16: 3-10, 1990.
10. Chirnside A, Urbaniak SJ, Prowse CV, Keller AJ: Coagulation abnormalities following intensive plasma exchange on the cell separator. Br J Haematol 48: 627-634, 1981.
11. Keller AJ, Urbaniak SJ: Intensive plasma exchange on the cell separator: Effects on serum immunoglobulins and complement components. Br J Haematol 38: 531-540, 1978.
12. Mokrzycki MH, Kaplan AA: Therapeutic plasma exchange: Complications and management. Am J Kidney Dis 23: 817-827, 1994.
13. Anonymous: The risk of transfusion-transmitted infection (editorial). N Engl J Med 327: 419-421, 1992.
14. Snyder HW, Cochran SK, Balint JP, et al: Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood 79: 2237-2245, 1992.
15. Esnault VLM, Testa A, Jayne DRW, Soulillou J-P, Guenel J: Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis. Nephron 65: 180-184, 1993.
16. Messerschmidt GL, Henry DH, Snyder HW, et al: Protein A immunoadsorption in the treatment of malignant disease. J Clin Oncol 6: 203-212, 1988.
17. Mastrangelo F, Pretagostini R, Berloco P, et al: Immunoadsorption with protein A in humoral acute rejection of kidney transplants: Multicenter experience. Transplant Proc 27: 892-895, 1995.
18. Olivari M-T, May CB, Johnson NA, Ring WS, Stephens MK: Treatment of acute vascular rejection with immunoadsorption. Circulation 90: II-70-73, 1994.
19. ® (abstract). Xth International Symposium on Atherosclerosis, Montreal, October 9-14, 1994.
20. Richter WO, Jacob BG, Ritter MM, Sühler K, Vierneisel K, Schwandt P: Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 42: 888-894, 1993.
21. Cohen S, Freeman T: Metabolic heterogeneity of human gamma globulin. Biochem J 76: 475-487, 1960.
22. Palmer, A, Welsh K, Gjorstrup P, Taube D, Bewick M, Thick M: Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet 7: 10-12, 1989.
23. Kiaa F, Laurian Y, Hiesse C, Tchernia G, Charpentier B: Five year experience with protein A immunoadsorption in patients with allo/auto-antibodies (anti-HLA antibodies, autoimmune bleeding disorders) and transplant patients with relapsing focal glomerular sclerosis. Transplant Proc 27: 1031-1032, 1995.
24. Branda RF, Miller WJ, Soltis RD, McCullough JJ: Immunoadsorption of human plasma with protein A-sepharose columns. Transfusion 26: 471-477, 1986.
25. Barocci S, Nocera A: In vitro removal of anti-HLA IgG antibodies from highly sensitized transplant recipients by immunoadsorption with protein A and protein G sepharose columns. Tranpl Int 6: 29-33, 1993.
26. Esnault V, Bignon JD, Testa A, Preud'Homme JL, Vergracht A, Soulillou JP: Effect of protein A immunoadsorption on panel lymphocyte reactivity in hyperimmunised patients awaiting kidney graft. Transplantation 50: 449-453, 1990.
27. Rock G: The application of protein A immunoadsorption to remove platelet alloantibodies. Transfusion 33: 192-194, 1993.
28. Chenoweth DE: The properties of human C5a anaphylatoxin. Contrib Nephrol 59: 51-71, 1987.
29. Silberstein LE, Naryshkin S, Haddad JJ, Strauss JF: Calcium homeostasis during therapeutic plasma exchange. Transfusion 26: 151-155, 1986.
30. Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S: Infectious complications with plasmapheresis in rapidly progressing glomerulonephritis. JAMA 28: 2423-2426, 1980.
31. Pohl MA, Lan S-P, Berl T: Lupus Nephritis Collaborative Study Group: Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann Intern Med 114: 924-929, 1991.
32. Huestis DW: Mortality in therapeutic haemapheresis (letter). Lancet 1: 1043, 1983.
33. Bambauer R, Jutzler GA, Albrecht D, Keller HE, Kohler M: Indications for plasmapheresis and selection of different substitution solutions. Biomater Artif Cell Artif Organs 17: 9-27, 1989.
34. Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1: 466-469, 1977.
35. Käbisch A, Kroll H, Wedi B, Kiefel V, Pralle H, Mueller-Eckhardt C: Severe adverse effects of protein A immunoadsorption (letter). Lancet 343: 116, 1994.